Damora Therapeutics, Inc.
DMRA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001800315
In the last 90 days, Damora Therapeutics, Inc. insiders filed 0 open-market purchases and 1 sale; 104 institutions reported holding it in 13F filings for Q2 2026, worth $1.67B in total; Viking Global Investors is the only superinvestor holding it.
13F holders, Q1 2021
Institutional positions in Damora Therapeutics, Inc. as of Mar 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 19
- No complete 13F data for Q4 2020
- Shares held
- 13.7M
- No complete 13F data for Q4 2020
- Total value
- $82.9M
- No complete 13F data for Q4 2020
Holders and value by quarter
Institutions reporting DMRA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 104 | $1.67B |
| Q1 2026 | 65 | $1.45B |
| Q4 2025 | 18 | $65.5M |
| Q3 2025 | 12 | $633.3K |
| Q2 2025 | 9 | $451.5K |
| Q1 2025 | 11 | $442.4K |
| Q4 2024 | 10 | $660.7K |
| Q3 2024 | 10 | $1.56M |
| Q2 2024 | 22 | $1.91M |
| Q1 2024 | 26 | $3.09M |
| Q4 2023 | 22 | $2.77M |
| Q3 2023 | 22 | $3.92M |
| Q2 2023 | 27 | $25.7M |
| Q1 2023 | 26 | $17.8M |
| Q4 2022 | 22 | $10.2M |
| Q3 2022 | 26 | $17.3M |
| Q2 2022 | 23 | $15.7M |
| Q1 2022 | 25 | $21.0M |
| Q4 2021 | 26 | $30.5M |
| Q3 2021 | 25 | $37.2M |
| Q2 2021 | 27 | $57.4M |
| Q1 2021 | 19 | $82.9M |
Institutions, Q1 2021
Shares, value and share of portfolio for each institution holding Damora Therapeutics, Inc..
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| OrbiMed Advisors LLC | 4,090,937 | $24.9M | 0.23% | – | – |
| Novo Holdings A/S | 2,497,791 | $15.2M | 0.63% | – | – |
| Cormorant Asset Management, LP | 2,150,732 | $13.1M | 0.38% | – | – |
| Soleus Capital Management, L.P. | 1,512,648 | $9.19M | 1.66% | – | – |
| Janus Henderson Group PLC | 1,321,929 | $7.83M | 0.00% | – | – |
| BlackRock Inc. | 538,896 | $3.27M | 0.00% | – | – |
| Maverick Capital LtdSuperinvestorMaverick Capital | 482,672 | $2.90M | 0.03% | – | – |
| Sphera Funds Management Ltd. | 448,016 | $2.72M | 0.25% | – | – |
| Laurion Capital Management LP | 207,552 | $1.26M | 0.02% | – | – |
| FMR LLC | 133,333 | $810.0K | 0.00% | – | – |
| Asymmetry Capital Management, L.P. | 113,515 | $690.0K | 0.36% | – | – |
| Millennium Management LLC | 82,850 | $503.0K | 0.00% | – | – |
| Tudor Investment Corp Et Al | 57,957 | $352.0K | 0.01% | – | – |
| Federated Hermes, Inc. | 20,000 | $122.0K | 0.00% | – | – |
| Weiss Multi-Strategy Advisers LLC | 16,154 | $98.0K | 0.00% | – | – |
| Goldman Sachs Group Inc | 13,397 | $81.0K | 0.00% | – | – |
| Bank of America Corp | 4,948 | $30.0K | 0.00% | – | – |
| Harbour Investments, Inc. | 100 | $1.00K | 0.00% | – | – |
| Wells Fargo & Company | 38 | $0 | 0.00% | – | – |